Search research articles
Contact Us
Filters
Showing results (1-10 of 288) with videos related to
Page
of 29
Sort By:
Hepatology International
|
April 19, 2020
Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?
Rong Fan, Jinlin Hou
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 21, 2020
Reply
Rong Fan, Jinlin Hou
Alimentary Pharmacology & Therapeutics
|
November 6, 2021
Letter: cross-linkage between bacterial taxonomy and gene functions-a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease
Weijia Han, Jinlin Hou
Alimentary Pharmacology & Therapeutics
|
August 11, 2021
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' reply
Rong Fan, Jinlin Hou
International Journal of Medical Sciences
|
April 15, 2006
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection
Zhihua Liu, Jinlin Hou
Hepatology International
|
December 3, 2020
HBx mutations emerged during antiviral therapy: a new face of a multifaceted HBV protein?
Bin Zhou, Weimeng He, Jinlin Hou
Frontiers in Genetics
|
October 18, 2013
Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs
Xiaoyong Zhang, Jinlin Hou, Mengji Lu
Cellular & Molecular Immunology
|
November 4, 2014
Role of interleukin-21 in HBV infection: friend or foe?
Yongyin Li, Libo Tang, Jinlin Hou
The New England Journal of Medicine
|
February 26, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. Reply
Jinlin Hou, Farouk Chughlay, Rémi Kazma
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 9, 2019
Reply
Xueru Yin, Zhihua Liu, Jinlin Hou
Page
of 29
Search research articles
Search
Showing results (1-10 of 288) with videos related to
Sort By:
Page
of 29
Hepatology International
|
April 19, 2020
Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?
Rong Fan, Jinlin Hou
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 21, 2020
Reply
Rong Fan, Jinlin Hou
Alimentary Pharmacology & Therapeutics
|
November 6, 2021
Letter: cross-linkage between bacterial taxonomy and gene functions-a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease
Weijia Han, Jinlin Hou
Alimentary Pharmacology & Therapeutics
|
August 11, 2021
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' reply
Rong Fan, Jinlin Hou
International Journal of Medical Sciences
|
April 15, 2006
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection
Zhihua Liu, Jinlin Hou
Hepatology International
|
December 3, 2020
HBx mutations emerged during antiviral therapy: a new face of a multifaceted HBV protein?
Bin Zhou, Weimeng He, Jinlin Hou
Frontiers in Genetics
|
October 18, 2013
Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs
Xiaoyong Zhang, Jinlin Hou, Mengji Lu
Cellular & Molecular Immunology
|
November 4, 2014
Role of interleukin-21 in HBV infection: friend or foe?
Yongyin Li, Libo Tang, Jinlin Hou
The New England Journal of Medicine
|
February 26, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. Reply
Jinlin Hou, Farouk Chughlay, Rémi Kazma
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 9, 2019
Reply
Xueru Yin, Zhihua Liu, Jinlin Hou
Page
of 29